On June 13, 2019, the results of the much-anticipated Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial were presented live at the SA AIDS 2019 conference in Durban, Sout... Read full article

Observational studies have raised concerns about the potential link between the use of progestin-only injectable contraception – specifically depot medroxyprogesterone acetate (DMPA) – and increased risk of HIV acquisition. In response, FHI 360 h... Read full article

Next week, more than 8,000 researchers, policy makers, and advocates from 160+ countries will gather in Vancouver, British Columbia, to discuss the future of women: their health, their strength, and their autonomy. Women... Read full article

YourChoice Therapeutics is attempting to revolutionize birth control options for women and men by developing options that are hormone-free, safe, easy to use, and effective. In men, the product disables the flagellated tail, inhibiting sperm motility... Read full article

In the future, preventing pregnancy may be as easy as putting on jewelry. According to an article in the Journal of Controlled Release, researchers at Georgia Tech hav... Read full article

Gloria dreams of a contraceptive and HIV prevention method that she can control. As a university student in Zambia, Gloria goes on dates in between working and studying. Some of the men have potential. She could imagine marrying one of them and ha... Read full article

Guest  bloggers are Danielle Harris of WCG Cares and Ashley Jackson of PSI. This post originally appeared on the PSI Impact blog. Read full article